These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

627 related items for PubMed ID: 2574066

  • 1. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis.
    Sharp T, Bramwell SR, Hjorth S, Grahame-Smith DG.
    Br J Pharmacol; 1989 Nov; 98(3):989-97. PubMed ID: 2574066
    [Abstract] [Full Text] [Related]

  • 2. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ, Bervoets K, Colpaert FC.
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [Abstract] [Full Text] [Related]

  • 3. Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378.
    Sharp T, Backus LI, Hjorth S, Bramwell SR, Grahame-Smith DG.
    Eur J Pharmacol; 1990 Feb 13; 176(3):331-40. PubMed ID: 1970304
    [Abstract] [Full Text] [Related]

  • 4. cis-(+)-8-OH-1-CH3-DPAT, (+)ALK-3, a novel stereoselective pharmacological probe for characterizing 5-HT release-controlling 5-HT1A autoreceptors. An in vivo brain microdialysis study.
    Hjorth S, Sharp T, Liu Y.
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar 13; 341(3):149-57. PubMed ID: 1692973
    [Abstract] [Full Text] [Related]

  • 5. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM, Green AR.
    Br J Pharmacol; 1985 Mar 13; 84(3):743-53. PubMed ID: 2580582
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin.
    Marsden CA, Martin KF.
    Br J Pharmacol; 1986 Oct 13; 89(2):277-86. PubMed ID: 2430656
    [Abstract] [Full Text] [Related]

  • 8. Stimulation of corticosterone secretion by the selective 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat.
    Przegaliński E, Budziszewska B, Warchoł-Kania A, Błaszczyńska E.
    Pharmacol Biochem Behav; 1989 Jun 13; 33(2):329-34. PubMed ID: 2530590
    [Abstract] [Full Text] [Related]

  • 9. Mediation of the antidepressant-like effect of 8-OH-DPAT in mice by postsynaptic 5-HT1A receptors.
    Luscombe GP, Martin KF, Hutchins LJ, Gosden J, Heal DJ.
    Br J Pharmacol; 1993 Mar 13; 108(3):669-77. PubMed ID: 8467355
    [Abstract] [Full Text] [Related]

  • 10. Effect of WAY-100135 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin1A receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis.
    Nakai K, Fujii T, Fujimoto K, Suzuki T, Kawashima K.
    Neurosci Res; 1998 May 13; 31(1):23-9. PubMed ID: 9704975
    [Abstract] [Full Text] [Related]

  • 11. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD, Neill J, Kidd EJ, Fozard JR.
    Eur J Pharmacol; 1987 Jan 06; 133(1):47-56. PubMed ID: 2881789
    [Abstract] [Full Text] [Related]

  • 12. Evidence that 5-HT2 receptors mediate the pressor effect of 8-OH-DPAT in the spinally pithed rat.
    Deckert V, Chaouloff F, Richer C, Elghozi JL.
    Arch Int Pharmacodyn Ther; 1990 Jan 06; 306():114-29. PubMed ID: 1981665
    [Abstract] [Full Text] [Related]

  • 13. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis.
    Fozard JR, Mir AK, Middlemiss DN.
    J Cardiovasc Pharmacol; 1987 Mar 06; 9(3):328-47. PubMed ID: 2437400
    [Abstract] [Full Text] [Related]

  • 14. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F, Jeanrenaud B.
    J Pharmacol Exp Ther; 1987 Dec 06; 243(3):1159-66. PubMed ID: 2826757
    [Abstract] [Full Text] [Related]

  • 15. 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis.
    Sharp T, Bramwell SR, Grahame-Smith DG.
    Br J Pharmacol; 1989 Feb 06; 96(2):283-90. PubMed ID: 2466516
    [Abstract] [Full Text] [Related]

  • 16. 8-Hydroxy-2-(di-n-propylamino) tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between the autoreceptor and the [3H] 5-HT recognition site.
    Middlemiss DN.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug 06; 327(1):18-22. PubMed ID: 6238235
    [Abstract] [Full Text] [Related]

  • 17. The novel 5-HT1A receptor antagonist, SDZ 216-525, decreases 5-HT release in rat hippocampus in vivo.
    Sharp T, McQuade R, Fozard JR, Hoyer D.
    Br J Pharmacol; 1993 Jul 06; 109(3):699-702. PubMed ID: 8102935
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
    Yamada J, Sugimoto Y, Horisaka K.
    Eur J Pharmacol; 1988 Sep 23; 154(3):299-304. PubMed ID: 2976671
    [Abstract] [Full Text] [Related]

  • 20. Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin.
    Chen NH, Reith ME.
    J Neurochem; 1995 Apr 23; 64(4):1585-97. PubMed ID: 7891086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.